PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Merck KGaA

Merck KGaA

MerckMerck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

www.merckgroup.com

Filters
List of articles in category Merck KGaA
Title Published Date
Merck Serono to finance the launch of the EspeRare Foundation 15 April 2013
Merck acquires cell culture media specialist Biochrom AG 22 August 2012
Merck transformation starts to yield first results 14 August 2012
Merck Serono announces final efficiency program for Switzerland 19 June 2012
Merck and Dr. Reddy's Laboratories announce collaboration to develop and commercialize biosimilars 06 June 2012
Merck total revenues increase 3.2% to € 2.6 billion 16 May 2012
Merck announces efficiency program across all businesses and regions 26 February 2012
Merck Received European Approval for Pen Injectors for Fertility Treatment 05 July 2011
Merck: Regulatory Update on Cladribine Tablets 23 June 2011
Merck Profit After Tax Jumps 77% to EUR 344 Million 29 April 2011
Merck Strengthens Research Cooperation With Israel 01 April 2011
Merck Acquires Microbiology Business of Biotest AG 22 March 2011
Reexamination of CHMP Opinion for Cladribine Tablets in MS 23 January 2011
Merck KGaA and sanofi-aventis to Investigate Novel Combinations Against Cancer 19 December 2010
Merck KGaA Profit After Tax Jumps 45% to EUR 215 Million 26 October 2010
Merck KGaA Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MS 12 October 2010
Merck Inaugurates New Material Research Center in Darmstadt 24 September 2010
"The Merck Way" Presented in a New Image Brochure and Film 17 September 2010
Merck KGaA's Cladribine Tablets for MS Approved in Russia 13 July 2010
Q1/2010: Merck Net Profit After Tax More Than Triples 30 April 2010

Page 2 of 3

  • Start
  • Prev
  • 1
  • 2
  • 3
  • Next
  • End
  1. You are here:  
  2. Home
  3. Merck KGaA

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2023 PharmaNews.eu. All Rights Reserved.